TrialAmerican journal of respiratory and critical care medicine2025

Telacebec, a Potent Agent in the Fight against Tuberculosis: Findings from a Randomized, Phase 2 Clinical Trial and Beyond.

Saskia Janssen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.